MedTweetorial: #tweetorial
Author: @DOMSinaiNYC
Type: #MedEd #case
Specialties: #nephrology #renal #IM
Topics: #HTN #SecondaryHypertension #ResistantHypertension #spironolactone #PATHWAY_2_Trial #reninoma https://t.co/bCCoL46i3I— MedTweetorials (@MedTweetorials) September 23, 2019